“ZAMRA Strengthens Surveillance to Tackle Illegal Medicines”
The Zambia Medicines Regulatory Authority (ZAMRA) has
reaffirmed its commitment to protecting public health through a strengthened
post-marketing surveillance system.
Speaking to Daily News in Lusaka, Mr Ludovic Katomtoka
Mwape, Senior Public Relations Officer at Zambia Medicines Regulatory Authority
(ZAMRA), stated that the system employs routine inspections, market sampling,
and intelligence-led investigations to detect and remove illegal and
substandard medicines from circulation.
Mwape emphasized that while challenges persist in informal
markets, ZAMRA’s surveillance teams have successfully seized numerous illegal
products, safeguarding consumers from potential harm.
ZAMRA acknowledged that rural and underserved communities
remain more vulnerable to unregistered medicines due to limited access to
licensed pharmacies, weaker regulatory oversight, and lower public awareness.
To address this, the authority has intensified outreach and inspection efforts,
alongside community education programs designed to raise awareness about the
dangers of unregistered medicines.
Concerns about potential shortages of essential drugs during
crackdowns were addressed by Mwape, who explained that ZAMRA conducts thorough
market assessments before enforcement actions. The authority works closely with
legitimate manufacturers and distributors to ensure uninterrupted supply of
registered medicines, and facilitates expedited registration and importation of
critical drugs when necessary.
Zambia also maintains strong ties with neighboring countries
through platforms such as the Southern African Development Community (SADC) and
bilateral agreements. These partnerships enable intelligence sharing, joint
operations, and harmonization of regulatory standards to curb cross-border
trafficking of unregistered medicines.
Mr. Mwape concluded that ZAMRA’s collaborative and strategic
approach is vital in tackling the transnational nature of illegal medicine
trade while ensuring citizens have access to safe, effective, and legitimate
medicines.
(c) All Rights Reserved.











